SAA1 and obesity disorder: Serum amyloid A (SAA) proteins are proposed mediators of inflammation and metabolism, with increased serum levels being associated with obesity, chronic hyperglycemia, insulin resistance and cardiovascular disease [16], [17], [18], [19], [20], [21].